6505--Betamethasone RFP
ID: 36E79724R0025Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0b358b6c59924a6e9aabce840f79a893/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.

    Point(s) of Contact
    Amber.Zavala@va.govAmber Zavala
    (708) 786-5245
    amber.zavala@va.gov
    Files
    Title
    Posted
    36E79724R0025_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a Request for Proposal (RFP) identified as 36E79724R0025 for the procurement of Betamethasone, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract will be awarded to a qualified offeror capable of ensuring a consistent supply. The contract term encompasses one year plus four optional one-year extensions, with distribution via the Pharmaceutical Prime Vendor Programs of the VA and DOD. Offerors must provide the specific drug name as labeled and a unique National Drug Code (NDC). The electronic solicitation is expected to be available on October 22, 2024, with responses due by November 5, 2024, at 2:30 PM Central Time. Estimated annual requirements include specific quantities of Betamethasone Dipropionate 0.05% Cream. The NAICS code relevant to this procurement is 325412. Interested suppliers are encouraged to frequently check for updates and are instructed to direct inquiries via email to the designated point of contact, Amber Zavala.
    36E79724R0025.docx
    The document is a solicitation for pharmaceutical products issued by the Department of Veterans Affairs (VA), specifically targeting Betamethasone Dipropionate Cream in varying quantities. It outlines the requisition, contract details, submission requirements, pricing specifics, and terms associated with the contract for vendors. Offerors are required to submit proposals that include competitive prices for a base year and four option years, with the mandatory inclusion of a 0.5% Cost Recovery Fee. The contract is structured to supply pharmaceuticals through the VA and Department of Defense's Prime Vendor Programs, ensuring products are available nationwide while adhering to the Drug Supply Chain Security Act regulations. The contractor must provide unique National Drug Codes (NDCs), comply with Good Manufacturing Practices, and ensure stringent packaging and labeling standards. The scope emphasizes maintaining a consistent supply and highlights penalties for non-compliance, including backorders and failure to meet delivery schedules. It is crucial for the contractor to secure business-to-business agreements with Prime Vendors throughout the contract's duration. This solicitation serves as a critical tool in facilitating essential medication supply to veterans, embodying the government's dedication to health care provision for service members.
    Lifecycle
    Title
    Type
    6505--Betamethasone RFP
    Solicitation
    6505--Betamethasone RFP
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Ketoconazole 2% Cream, a pharmaceutical product essential for treating various skin conditions. Offerors are required to submit pricing for the base year and four option years, ensuring compliance with the Cost Recovery Fee of 0.5%, and must provide unique National Drug Codes (NDC) for their proposed products. This procurement aims to establish a reliable supply chain for pharmaceutical needs while adhering to federal procurement standards, emphasizing the importance of FDA cGMP compliance for manufacturers or authorized distributors. Interested parties should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details regarding the solicitation process.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0046 770-25-1-801-0022 -National CMOP K0016 KETOCONAZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the National CMOP Contracting Office, is seeking to procure Ketoconazole 2% shampoo in various quantities for emergency delivery to multiple Compounding Medication Order Pharmacy (CMOP) facilities across the United States. The procurement includes specific item quantities, with a total of 27,600 units required, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to U.S. trade agreements. This acquisition is crucial for ensuring that veterans receive necessary pharmaceutical products in a timely manner. Interested vendors must submit their quotes by November 1, 2024, with an estimated award date of November 6, 2024, and should direct all inquiries and submissions to Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--Imiquimod 5% Cream and Placebo Manufacturing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified sources for the manufacturing and supply of Imiquimod 5% Cream and a placebo, as part of a clinical study focused on cancer prevention. This procurement aims to identify capable vendors, particularly Veteran-owned and small businesses, to fulfill the requirements outlined in the attached Request for Information (RFI) and Statement of Work (SOW). The selected contractor will be responsible for adhering to stringent Good Manufacturing Practices and ensuring compliance with federal regulations, including the Non-Manufacturer Rule and Buy American Act, while delivering between 30,000 and 165,000 units annually over a three-year contract period. Interested parties must submit their capabilities statements by November 1, 2024, and can direct inquiries to Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Aspirin 25 MG/Dipyridamole 200MG Sustained Action (SA) Capsules under solicitation number 36E79724R0034. The contract aims to establish a reliable supply source for these pharmaceuticals, which will be utilized by the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service, with an estimated annual requirement of 37,545 bottles. The contract will span one year with four optional one-year extensions, and interested offerors must submit their proposals electronically by the closing date of November 29, 2024. For further inquiries, potential bidders can contact Contract Specialist Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0045 762-25-1-040-0082 -Tucson CMOP KETOCANOZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of 27,192 units of Ketoconazole 2% Shampoo, specifically packaged in 120ML bottles, to be delivered to the Tucson CMOP facility in Arizona. This presolicitation notice (Solicitation Number: 36C77025Q0045) outlines the requirement for vendors to submit a complete solicitation package, including a signed SF1449 cover page, a price schedule in Excel format, and proof of state licensure in compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is crucial for ensuring the availability of essential pharmaceuticals for veteran care, with a delivery timeframe of 10 days after receipt of order (ARO) and a closing date for responses set for November 1, 2024, at 09:00 AM Central Time. Interested vendors should direct their inquiries and submissions to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--770-25-1-801-0013 - National CMOP CHLORHEXIDINE GLUCONATE 4% TOP LIQUID (VA-24-00109489)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of CHLORHEXIDINE GLUCONATE 4% TOP LIQUID for the National CMOP facility, under solicitation number VA-24-00109489. Vendors are required to submit a signed SF1449 cover page, a completed pricing schedule, and necessary licensing documents, ensuring compliance with federal regulations, including the Buy American Act and the Drug Supply Chain Security Act. This procurement is critical for providing quality pharmaceutical supplies to veterans, emphasizing the importance of adherence to strict acceptance criteria and logistical requirements. Quotes must be submitted by October 30, 2024, at 3:00 PM Central Time, and interested parties can contact Lacie A Nowak at lacie.nowak@va.gov for further information.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.